Valuation: CellaVision AB

Market Cap 3.64B 381M 331M 307M 284M 534M 36.39B 544M 1.43B 18.07B 1.43B 1.4B 60.78B P/E 2026 *
24.6x
P/E 2027 * 19.7x
Enterprise Value 3.43B 360M 312M 290M 267M 504M 34.33B 513M 1.34B 17.05B 1.35B 1.32B 57.34B EV / Sales 2026 *
4.38x
EV / Sales 2027 * 3.86x
Free-Float
83.08%
Yield 2026 *
1.8%
Yield 2027 * 2.11%
1 day-2.49%
1 week+6.76%
Current month+8.96%
1 month+8.96%
3 months+22.44%
6 months+0.68%
Current year-5.60%
1 week 138.4
Extreme 138.4
153.8
1 month 131.8
Extreme 131.8
153.8
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 70.75
Extreme 70.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap.
2/16/26 Buy 1,400 0.0059%
2/6/26 Buy

Founder

100,000 0.4193%
6/19/25 Sell

Founder

300 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-2.75%+6.76%-16.35%-32.39% 374M
-1.51%+0.18%+16.06%-40.79% 15.85B
-3.49%+4.17%-1.76%+92.47% 1.75B
-0.55%-0.66%-32.19%-81.15% 1.13B
+0.29%+2.67%-37.98%+15.42% 983M
-0.46%+2.94%-41.81%-53.27% 648M
+2.08%+6.38%-46.41%-55.48% 526M
-0.27%+2.15%+46.98%-52.98% 462M
-2.84%+3.70%-54.12%-61.72% 384M
-0.46%+6.68%+11.38%+8.98% 312M
Average -0.84%+3.48%-15.62%-26.09% 2.24B
Weighted average by Cap. -1.13%+2.20%+5.56%-30.40%

Financials

2026 *2027 *
Net sales 784M 82.08M 71.3M 66.21M 61.06M 115M 7.84B 117M 307M 3.89B 308M 301M 13.09B 877M 91.87M 79.8M 74.1M 68.34M 129M 8.77B 131M 343M 4.36B 345M 337M 14.65B
Net income 148M 15.48M 13.45M 12.49M 11.52M 21.69M 1.48B 22.08M 57.88M 734M 58.13M 56.86M 2.47B 185M 19.39M 16.84M 15.64M 14.42M 27.17M 1.85B 27.66M 72.5M 919M 72.82M 71.23M 3.09B
Net Debt -206M -21.58M -18.74M -17.4M -16.05M -30.23M -2.06B -30.78M -80.67M -1.02B -81.02M -79.25M -3.44B -252M -26.43M -22.95M -21.31M -19.66M -37.03M -2.52B -37.7M -98.8M -1.25B -99.24M -97.06M -4.21B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
26-07-30 SEK 148.40 -2.75% 16,806
26-07-29 SEK 152.60 +5.68% 37,837
26-07-28 SEK 144.40 +1.83% 18,243
26-07-27 SEK 141.80 +1.29% 13,598
26-07-24 SEK 140.00 +0.72% 14,466
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
152.60SEK
Average target price
175.67SEK
Spread / Average Target
+15.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock